Finally, although higher IF1 values correlate with a lower risk of CHD and better outcomes in patients with CHD, it remains unclear whether therapeutically driven enhancement of IF1 concentration may generate comparable outcomes. This evidence concerns the gene ATP5IF1 and coronary artery disorder.